Silo Pharma, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2021 to Q1 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Silo Pharma, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2022.
- Silo Pharma, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $0.000, a 100% decline year-over-year.
- Silo Pharma, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $24.9K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)